Elixiron Immunotherapeutics specializes in precision immunotherapies for neuroinflammation, autoimmune diseases, and cancer
Elixiron Immunotherapeutics specializes in precision immunotherapies for neuroinflammation, autoimmune diseases, and cancer. The company is developing innovative therapies such as Enrupatinib for Alzheimer's and Indemakitug for vitiligo, leveraging advanced immunological insights and proprietary technology platforms.